All Stories

FDA taps insider Scott Steele to lead CBER on acting basis after Peter Marks departure

Amid a dramatic reshaping of the federal healthcare apparatus, the FDA has named an acting leader of its Center for Biologics Evaluation and Research.

Apr 2, 2025 - 16:41
 0
FDA taps insider Scott Steele to lead CBER on acting basis after Peter Marks departure
Amid a dramatic reshaping of the federal healthcare apparatus, the FDA has named an acting leader of its Center for Biologics Evaluation and Research.
Read More

Tags:

Previous Article

Amid uncertainty in the US, Boehringer Ingelheim projects 'slight' revenue incre...

Next Article

Newly launched genetic medicine CDMO acquires Landmark Bio

Related Posts

Regulatory tracker: Kelun's TROP2 ADC snares another approval in China

Regulatory tracker: Kelun's TROP2 ADC snares another ap...

Mar 13, 2025  0

Fierce Pharma Engage: The Premier Gathering for Pharma Marketing Leaders

Fierce Pharma Engage: The Premier Gathering for Pharma ...

Mar 26, 2025  0

Starboard CEO gets seat on Kenvue's board as activist investor inks 'cooperation agreement' with consumer giant

Starboard CEO gets seat on Kenvue's board as activist i...

Mar 10, 2025  0